• Home
  • CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.

Author List
Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, Krishnan V, Hatakeyama J, Dorigo O, Barkal LJ, Weissman IL
Publication
Nature
Publication ID (Profile URL)
https://researcherprofiles.org/profile/69257863
Publication Year
2019
PubMed ID
31367043
Publication Title
Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, Krishnan V, Hatakeyama J, Dorigo O, Barkal LJ, Weissman IL. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019 08; 572(7769):392-396.